Form 4: Eastman Chemical Co. CEO Mark Costa Reports Stock Option Grant and Restricted Stock Units Acquisition
SEC Form 4 Filing
Eastman Chemical Co.'s CEO, Mark Costa, reported the acquisition of stock options and restricted stock units, according to a Form 4 filing with the SEC.
Summary
- Mark Costa, CEO and Board Chair of Eastman Chemical Co., reported transactions involving derivative securities.
- On February 27, 2024, Costa acquired employee stock options for 108,139 shares of common stock at an exercise price of $86.15.
- These options vest in three equal installments starting February 27, 2025, and expiring on February 26, 2034.
- Additionally, Costa acquired 21,887 restricted stock units (RSUs) which represent a contingent right to receive one share of Eastman Chemical Co. common stock each.
- These RSUs will vest and payout in unrestricted shares on February 27, 2027, contingent upon continued employment.
- Following these transactions, Costa directly owns 108,139 employee stock options and 21,887 restricted stock units.
Sentiment
Score: 7
Explanation: The sentiment is neutral to positive. The grant of stock options and RSUs is a standard practice and aligns management's interests with shareholders. The vesting schedule encourages long-term commitment.
Positives
- The grant of stock options and RSUs to the CEO aligns his interests with those of the shareholders, incentivizing him to improve company performance.
- The vesting schedule of the options and RSUs encourages long-term commitment from the CEO.
Future Outlook
The vesting of the restricted stock units is subject to continued employment, suggesting an expectation of the CEO's continued service.
Industry Context
Stock option and RSU grants are common compensation practices for executives in publicly traded companies, aligning their interests with shareholders and incentivizing long-term value creation.
Comparison to Industry Standards
- Executive compensation packages, including stock options and RSUs, are standard practice among large chemical companies such as Dow, BASF, and LyondellBasell.
- The vesting schedules and exercise prices are generally structured to align with long-term performance goals and industry benchmarks for executive compensation.
Stakeholder Impact
- Shareholders may view the stock option and RSU grants positively, as they incentivize the CEO to improve company performance and increase shareholder value.
- Employees may see the grants as a sign of the company's commitment to its leadership.
Key Dates
| Date | Description |
|---|---|
| 02/27/2024 | Date of stock option and restricted stock unit acquisition. |
| 02/27/2025 | First vesting date for one-third of the stock options. |
| 02/27/2026 | Second vesting date for one-third of the stock options. |
| 02/27/2027 | Final vesting date for one-third of the stock options and vesting date for the restricted stock units. |
| 02/26/2034 | Expiration date of the stock options. |
| 02/29/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.